▁Sub 10.375
title 8.375
: 4.76171875
▁Company 8.140625
▁a 7.26171875
ims 6.52734375
▁to 1.0947265625
▁revolution 7.81640625
ize 0.71875
▁cancer 12.3984375
▁treatment 2.646484375
▁with 1.9599609375
▁prom 7.20703125
ising 1.173828125
▁drug 6.72265625
▁candidates 3.17578125
<0x0A> 4.79296875
[ 6.40234375
City 9.296875
, 2.72265625
▁Date 5.421875
] 1.3486328125
▁- 4.83984375
▁Ch 6.83984375
iros 10.453125
cience 1.283203125
▁Group 6.60546875
▁pl 6.17578125
c 0.01323699951171875
, 3.12890625
▁a 1.7841796875
▁leading 3.53515625
▁ph 3.91015625
arma 0.0255584716796875
ce 0.0213470458984375
ut 9.083747863769531e-05
ical 0.0007305145263671875
▁company 0.95263671875
, 1.025390625
▁has 1.708984375
▁announced 1.134765625
▁significant 6.37109375
▁progress 0.763671875
▁in 0.755859375
▁their 4.53125
▁rel 7.96875
ent 0.440185546875
less 0.004810333251953125
▁purs 1.443359375
uit 0.0030155181884765625
▁of 0.66162109375
▁ground 5.43359375
bre 1.0234375
aking 0.0004639625549316406
▁cancer 1.1337890625
▁treat 1.0966796875
ments 0.001155853271484375
. 0.8876953125
▁Following 5.68359375
▁successful 5.05859375
▁pre 2.57421875
cl 0.2548828125
in 6.651878356933594e-05
ical 0.002532958984375
▁studies 1.6640625
, 1.150390625
▁the 0.99609375
▁company 1.220703125
▁has 0.95361328125
▁selected 5.26953125
▁two 2.6328125
▁highly 5.80078125
▁prom 0.54296875
ising 0.0005917549133300781
▁anti 6.04296875
- 0.0305633544921875
can 0.367431640625
cer 0.0014791488647460938
▁comp 2.693359375
ounds 0.00868988037109375
▁for 1.712890625
▁evaluation 5.625
▁in 0.309326171875
▁human 2.3203125
▁tri 1.2216796875
als 0.00010061264038085938
. 0.53564453125
▁This 4.43359375
▁development 4.27734375
▁holds 7.71484375
▁immense 3.85546875
▁potential 1.0390625
▁for 0.54345703125
▁transform 4.24609375
ing 0.1217041015625
▁the 0.69091796875
▁landscape 4.61328125
▁of 0.0885009765625
▁cancer 0.326904296875
▁ther 2.978515625
apy 0.1898193359375
. 0.88671875
<0x0A> 1.0458984375
Ch 1.8486328125
iros 0.07232666015625
cience 0.006969451904296875
▁Group 1.3056640625
▁pl 0.6318359375
c 0.00022161006927490234
' 3.912109375
s 0.00995635986328125
▁un 7.30078125
wa 1.8916015625
ver 8.952617645263672e-05
ing 0.004283905029296875
▁commit 1.1142578125
ment 0.00109100341796875
▁to 0.21142578125
▁adv 3.5078125
ancing 0.05767822265625
▁scientific 4.15625
▁understanding 4.828125
▁and 1.279296875
▁impro 2.85546875
ving 0.0002760887145996094
▁patient 1.5390625
▁out 1.1337890625
comes 0.002864837646484375
▁fu 7.65234375
els 0.0007028579711914062
▁their 1.94140625
▁constant 5.546875
▁search 2.330078125
▁for 0.06134033203125
▁novel 2.05078125
▁treatment 3.15234375
▁options 0.505859375
. 0.5615234375
▁By 4.41796875
▁lever 2.626953125
aging 0.0005946159362792969
▁its 2.75390625
▁expert 2.865234375
ise 0.0306854248046875
▁in 0.30615234375
▁drug 1.283203125
▁discovery 0.57177734375
▁and 0.662109375
▁development 0.5654296875
, 0.1328125
▁the 0.27099609375
▁company 0.1009521484375
▁has 1.58984375
▁successfully 2.833984375
▁identified 1.3701171875
▁two 1.416015625
▁comp 2.69140625
ounds 0.01056671142578125
▁demonstr 6.55859375
ating 0.001537322998046875
▁exception 2.904296875
al 0.028472900390625
▁effic 2.072265625
acy 5.2809715270996094e-05
▁against 1.5908203125
▁various 3.412109375
▁can 1.9609375
cers 0.0012655258178710938
▁during 9.5390625
▁pre 0.58154296875
cl 0.030426025390625
in 5.245208740234375e-06
ical 0.0011138916015625
▁testing 1.876953125
▁phases 7.359375
. 0.072998046875
<0x0A> 0.744140625
The 1.3798828125
▁first 1.607421875
▁comp 0.84033203125
ound 0.0029926300048828125
, 0.74267578125
▁scientific 9.8203125
ally 0.57421875
▁l 7.59375
abeled 0.0007271766662597656
▁CS 6.28515625
- 0.6796875
1 1.080078125
0 1.3173828125
0 1.5830078125
9 3.50390625
7 3.724609375
, 0.7626953125
▁has 1.8408203125
▁shown 1.578125
▁remarkable 2.318359375
▁potential 3.80859375
▁in 0.80419921875
▁select 5.58984375
ively 0.52685546875
▁target 1.0810546875
ing 0.00341033935546875
▁and 2.423828125
▁neutral 4.69140625
izing 0.0100250244140625
▁solid 7.75390625
▁tum 0.0714111328125
ors 0.6708984375
, 1.9033203125
▁particularly 3.138671875
▁those 1.4326171875
▁resist 3.833984375
ant 0.0012121200561523438
▁to 0.01727294921875
▁conventional 2.46875
▁treat 2.5
ments 5.0067901611328125e-05
. 0.18896484375
▁During 5.58984375
▁animal 3.81640625
▁studies 0.96630859375
, 0.11627197265625
▁CS 1.4599609375
- 0.0027618408203125
1 0.003353118896484375
0 0.0008177757263183594
0 0.000965118408203125
9 0.0011377334594726562
7 0.00185394287109375
▁displayed 3.78125
▁robust 4.69140625
▁in 3.1015625
hib 0.452880859375
ition 0.43505859375
▁of 0.1971435546875
▁tum 1.439453125
or 0.06475830078125
▁growth 0.322021484375
, 1.60546875
▁leading 4.3125
▁to 0.1572265625
▁complete 3.96875
▁rem 1.873046875
ission 0.140869140625
▁in 0.485595703125
▁a 2.30859375
▁significant 3.697265625
▁proportion 2.546875
▁of 0.005580902099609375
▁treated 2.29296875
▁subjects 5.3046875
. 0.11859130859375
▁This 2.962890625
▁encourag 3.3203125
ing 0.0384521484375
▁result 1.2734375
▁positions 6.734375
▁the 0.86328125
▁comp 0.8388671875
ound 0.0012063980102539062
▁as 1.314453125
▁a 0.25146484375
▁strong 2.998046875
▁candidate 0.61962890625
▁for 0.261474609375
▁further 1.8056640625
▁evaluation 1.97265625
▁in 0.1619873046875
▁human 0.87939453125
▁tri 0.432861328125
als 4.4226646423339844e-05
. 0.296875
<0x0A> 0.16162109375
The 0.55810546875
▁second 0.07550048828125
▁comp 0.21826171875
ound 0.0004982948303222656
, 0.0821533203125
▁known 4.75
▁as 0.75390625
▁CS 0.306640625
- 0.03826904296875
1 1.0234375
2 2.62890625
9 2.732421875
8 2.578125
3 2.806640625
, 0.116455078125
▁exhib 3.96875
its 0.59130859375
▁a 2.3671875
▁unique 1.51953125
▁mechanism 0.9716796875
▁of 0.020477294921875
▁action 0.041900634765625
▁in 3.18359375
▁dis 5.7109375
m 4.09765625
ant 0.0020275115966796875
ling 0.005016326904296875
▁the 2.0703125
▁intr 5.19921875
icate 0.986328125
▁structures 3.87109375
▁of 0.1973876953125
▁blood 4.92578125
▁can 3.982421875
cers 0.0011234283447265625
▁such 2.822265625
▁as 0.003276824951171875
▁le 0.55908203125
uk 0.0257720947265625
emia 0.2020263671875
▁and 0.80810546875
▁l 0.4677734375
ym 0.0003056526184082031
ph 4.6133995056152344e-05
oma 0.0533447265625
. 0.1929931640625
▁Initial 5.6875
▁investig 5.09375
ations 0.1258544921875
▁suggest 2.130859375
▁that 0.2347412109375
▁CS 0.68359375
- 0.0013093948364257812
1 0.0009984970092773438
2 0.0012359619140625
9 0.0010852813720703125
8 0.0023345947265625
3 0.0020294189453125
▁dis 6.49609375
rupt 0.4287109375
s 0.0015230178833007812
▁cancer 2.859375
▁cell 1.21875
▁surv 3.48046875
ival 0.001476287841796875
▁path 2.3125
ways 0.0013427734375
, 1.0048828125
▁offering 6.08984375
▁a 0.9521484375
▁potential 2.86328125
▁break 3.986328125
through 0.0115966796875
▁for 1.3798828125
▁patients 2.154296875
▁with 1.1328125
▁limited 6.625
▁treatment 0.153076171875
▁options 0.040283203125
. 0.076904296875
▁Animal 9.1484375
▁studies 0.22607421875
▁have 0.54345703125
▁demonstrated 1.158203125
▁un 6.62890625
pre 0.31787109375
ced 4.088878631591797e-05
ented 0.0035247802734375
▁effic 1.5205078125
acy 3.743171691894531e-05
▁in 1.3779296875
▁reducing 2.8046875
▁tum 0.2666015625
or 0.0217742919921875
▁bur 0.8154296875
den 0.0231475830078125
, 1.3447265625
▁making 5.890625
▁CS 0.5615234375
- 0.0010547637939453125
1 0.0007224082946777344
2 0.0006165504455566406
9 0.0004887580871582031
8 0.0007557868957519531
3 0.0008130073547363281
▁a 0.50634765625
▁remarkable 7.05078125
▁prospect 3.87109375
▁in 1.9189453125
▁the 0.88818359375
▁fight 1.3037109375
▁against 0.01386260986328125
▁h 5.30078125
emat 0.01117706298828125
ological 0.36083984375
▁m 0.64599609375
align 0.00026154518127441406
an 0.01837158203125
cies 2.849102020263672e-05
. 0.056182861328125
<0x0A> 0.09429931640625
Dr 3.677734375
. 0.0914306640625
▁K 4.68359375
atherine 3.50390625
▁Nelson 7.0390625
, 0.11663818359375
▁Chief 1.4765625
▁Scient 0.8271484375
ific 0.00699615478515625
▁Officer 0.0212554931640625
▁at 0.95068359375
▁Ch 0.0255584716796875
iros 0.00640106201171875
cience 0.001678466796875
▁Group 0.28173828125
▁pl 0.76806640625
c 5.8531761169433594e-05
, 0.173828125
▁expressed 4.046875
▁her 0.9248046875
▁excitement 0.470947265625
▁about 1.7490234375
▁these 1.6064453125
▁select 7.98046875
▁comp 3.931640625
ounds 0.0092926025390625
, 2.083984375
▁saying 1.3505859375
, 0.33935546875
▁" 0.0377197265625
The 2.35546875
▁potential 4.015625
▁of 0.876953125
▁CS 1.224609375
- 0.01103973388671875
1 0.0099029541015625
0 0.11102294921875
0 0.0010280609130859375
9 0.00098419189453125
7 0.0011615753173828125
▁and 0.1300048828125
▁CS 0.005359649658203125
- 0.0009508132934570312
1 0.0014123916625976562
2 0.0005526542663574219
9 0.0008282661437988281
8 0.0009055137634277344
3 0.00113677978515625
▁cannot 4.4921875
▁be 0.006862640380859375
▁over 0.431640625
st 0.055755615234375
ated 0.00011241436004638672
. 0.1650390625
▁They 3.294921875
▁represent 1.5400390625
▁a 1.2646484375
▁significant 1.6220703125
▁step 2.005859375
▁forward 0.424560546875
▁in 0.1761474609375
▁target 4.83984375
ed 1.470703125
▁cancer 0.6298828125
▁ther 0.74365234375
ap 1.61328125
ies 0.00045752525329589844
▁and 1.51953125
▁hold 2.47265625
▁the 1.109375
▁promise 0.61865234375
▁to 1.1982421875
▁res 4.859375
hape 0.0037860870361328125
▁the 0.34326171875
▁treatment 2.171875
▁landscape 0.2353515625
▁for 0.56494140625
▁patients 0.98779296875
▁batt 3.509765625
ling 0.0001405477523803711
▁various 2.421875
▁m 3.033203125
align 0.00018608570098876953
an 0.034637451171875
cies 2.777576446533203e-05
." 0.6435546875
<0x0A> 0.11968994140625
With 4.921875
▁the 2.23046875
▁selection 4.3125
▁of 0.01544189453125
▁these 0.96044921875
▁two 1.44921875
▁comp 0.92431640625
ounds 0.0022735595703125
▁for 3.005859375
▁human 2.330078125
▁tri 0.32373046875
als 4.5418739318847656e-05
, 0.08807373046875
▁Ch 0.2841796875
iros 0.0047149658203125
cience 0.0012006759643554688
▁Group 0.10430908203125
▁pl 0.3525390625
c 5.1021575927734375e-05
▁is 1.7607421875
▁emb 5.609375
ark 0.0997314453125
ing 0.0014667510986328125
▁on 0.055145263671875
▁the 2.54296875
▁next 0.356689453125
▁critical 4.45703125
▁phase 0.73974609375
▁of 0.27587890625
▁drug 2.6015625
▁development 0.11859130859375
. 0.6591796875
▁R 8.34375
ig 1.4541015625
orous 0.1302490234375
▁testing 2.203125
▁on 5.1953125
▁human 1.7138671875
▁subjects 0.6279296875
▁will 0.50830078125
▁assess 4.4375
▁the 0.4453125
▁safety 1.341796875
, 1.91796875
▁toler 1.0693359375
ability 0.0328369140625
, 0.22021484375
▁and 0.12139892578125
▁effic 0.3603515625
acy 3.6954879760742188e-06
▁of 0.031707763671875
▁the 1.0732421875
▁comp 0.64013671875
ounds 0.03619384765625
, 1.794921875
▁opening 4.91015625
▁doors 4.04296875
▁to 0.2003173828125
▁potential 2.77734375
▁regul 3.669921875
atory 0.00020778179168701172
▁appro 0.260009765625
val 0.00011646747589111328
▁and 1.40625
▁subsequent 3.869140625
▁avail 4.109375
ability 0.00026988983154296875
▁for 1.5244140625
▁patients 0.4404296875
. 0.97216796875
<0x0A> 0.433349609375
To 4.359375
▁ensure 6.7109375
▁the 1.216796875
▁highest 1.1025390625
▁standards 1.3388671875
▁of 0.29150390625
▁patient 2.85546875
▁care 1.4345703125
▁and 1.6015625
▁regul 5.78125
atory 0.0002696514129638672
▁comp 0.1478271484375
liance 0.0009746551513671875
, 0.046142578125
▁Ch 0.298095703125
iros 0.004169464111328125
cience 0.00103759765625
▁Group 0.057647705078125
▁pl 0.0504150390625
c 1.0848045349121094e-05
▁will 2.52734375
▁collabor 2.50390625
ate 0.00507354736328125
▁with 0.14013671875
▁ren 3.69921875
owned 0.0005774497985839844
▁on 4.94140625
col 0.37109375
ogy 0.00010085105895996094
▁cent 1.8232421875
ers 0.01148223876953125
▁and 1.470703125
▁vision 11.609375
ary 0.053466796875
▁clin 1.896484375
ical 0.0955810546875
▁investig 2.66015625
ators 0.0075836181640625
▁across 3.12890625
▁the 0.07666015625
▁country 2.21875
. 0.270751953125
▁T 3.576171875
ogether 0.09796142578125
, 0.07293701171875
▁they 0.986328125
▁will 0.1650390625
▁design 4.01953125
, 2.62890625
▁execute 2.166015625
, 0.07318115234375
▁and 0.060760498046875
▁analyze 1.4130859375
▁the 1.4482421875
▁human 3.921875
▁tri 0.370849609375
als 3.1948089599609375e-05
▁met 12.8515625
icul 0.0014295578002929688
ously 0.0026607513427734375
, 1.0341796875
▁gather 6.6171875
ing 0.00690460205078125
▁in 1.9306640625
valu 0.024078369140625
able 4.7326087951660156e-05
▁data 1.126953125
▁to 1.357421875
▁inform 1.875
▁future 1.1435546875
▁treatment 2.623046875
▁strateg 1.517578125
ies 2.110004425048828e-05
. 0.5830078125
<0x0A> 0.44189453125
Cons 7.5703125
ider 0.78369140625
ing 0.495361328125
▁the 0.452392578125
▁immense 4.26171875
▁potential 0.4638671875
▁and 4.3515625
▁hope 7.765625
▁these 2.671875
▁comp 0.70166015625
ounds 0.0030269622802734375
▁hold 0.611328125
, 0.72900390625
▁exper 6.86328125
ts 0.00012195110321044922
▁and 3.541015625
▁patient 4.125
▁advoc 0.07012939453125
ates 0.31689453125
▁in 6.0234375
▁the 0.1566162109375
▁field 1.107421875
▁are 0.8505859375
▁deeply 6.15234375
▁optim 1.2578125
istic 5.602836608886719e-05
▁about 0.12042236328125
▁the 0.469970703125
▁progress 4.12890625
▁being 1.7197265625
▁made 0.0122222900390625
▁by 1.150390625
▁Ch 0.35107421875
iros 0.004642486572265625
cience 0.00115203857421875
▁Group 0.042388916015625
▁pl 0.04266357421875
c 8.106231689453125e-06
. 0.22021484375
▁The 2.45703125
▁selection 3.501953125
▁of 0.0194244384765625
▁CS 1.6220703125
- 0.004047393798828125
1 0.0106964111328125
0 0.06787109375
0 0.0007605552673339844
9 0.0007338523864746094
7 0.0012960433959960938
▁and 0.06671142578125
▁CS 0.0034847259521484375
- 0.0006260871887207031
1 0.0009331703186035156
2 0.00022912025451660156
9 0.0004901885986328125
8 0.0013446807861328125
3 0.0008730888366699219
▁for 2.193359375
▁human 0.6796875
▁tri 0.1158447265625
als 3.349781036376953e-05
▁sign 3.73046875
ifies 0.0026397705078125
▁a 0.66015625
▁major 2.4765625
▁step 1.6083984375
▁forward 0.2432861328125
, 5.1484375
▁inst 8.4140625
illing 0.2666015625
▁confidence 1.474609375
▁in 0.576171875
▁the 0.43603515625
▁possibilities 6.5859375
▁these 4.53125
▁comp 0.441162109375
ounds 0.0012235641479492188
▁may 3.396484375
▁offer 1.861328125
▁in 2.4375
▁the 0.471923828125
▁fight 1.02734375
▁against 0.0077667236328125
▁cancer 0.1893310546875
. 0.052886962890625
<0x0A> 0.31298828125
As 4.4921875
▁Ch 2.4296875
iros 0.005649566650390625
cience 0.0009937286376953125
▁Group 0.044708251953125
▁pl 0.049652099609375
c 1.9550323486328125e-05
▁moves 3.724609375
▁closer 2.138671875
▁to 0.048828125
▁the 1.5390625
▁human 4.5078125
▁tri 0.2333984375
als 1.6927719116210938e-05
▁phase 0.9443359375
, 0.1463623046875
▁the 1.04296875
▁entire 5.54296875
▁medical 3.23828125
▁community 0.25732421875
▁eager 4.6875
ly 0.0001627206802368164
▁a 0.051239013671875
wa 6.198883056640625e-06
its 4.887580871582031e-06
▁the 0.43359375
▁results 0.8134765625
. 0.90869140625
▁The 1.6201171875
▁company 1.220703125
' 0.611328125
s 0.0005846023559570312
▁t 5.94921875
ire 0.423828125
less 0.0004916191101074219
▁purs 1.0478515625
uit 0.010406494140625
▁of 0.145751953125
▁solutions 5.9921875
▁to 1.1396484375
▁combat 4.10546875
▁cancer 0.259033203125
▁opens 6.6640625
▁up 1.8544921875
▁new 2.67578125
▁a 1.2021484375
ven 0.0018205642700195312
ues 7.748603820800781e-06
▁of 1.509765625
▁hope 0.7841796875
▁and 1.4921875
▁insp 3.1953125
ires 0.396240234375
▁renew 4.6640625
ed 0.0012311935424804688
▁determ 3.62109375
ination 1.0132789611816406e-05
▁in 1.564453125
▁the 0.60791015625
▁battle 3.287109375
▁against 0.0784912109375
▁this 0.83740234375
▁dead 1.318359375
ly 0.0022449493408203125
▁disease 0.0745849609375
. 0.005626678466796875
<0x0A> 0.427978515625
Dis 5.34375
cla 0.3603515625
imer 6.67572021484375e-06
: 0.416259765625
▁The 0.845703125
▁content 3.1328125
▁of 1.0205078125
▁this 0.318603515625
▁press 1.1259765625
▁release 0.005191802978515625
▁is 0.671875
▁not 1.0224609375
▁intended 1.8603515625
▁to 0.21240234375
▁be 0.68310546875
▁a 0.66259765625
▁substitute 0.493408203125
▁for 0.00247955322265625
▁professional 0.0117340087890625
▁medical 0.0745849609375
▁advice 0.059051513671875
, 0.0501708984375
▁diagn 0.1097412109375
osis 0.0021991729736328125
, 0.246826171875
▁or 0.00547027587890625
▁treatment 0.00405120849609375
. 0.0149993896484375
▁Always 0.71728515625
▁seek 0.005290985107421875
▁the 0.0308990478515625
▁advice 0.0207366943359375
▁of 0.0029296875
▁your 0.0797119140625
▁phys 0.057037353515625
ician 0.0012187957763671875
▁or 0.0232391357421875
▁other 0.0831298828125
▁qualified 0.0024566650390625
▁health 0.013824462890625
▁provider 0.818359375
▁with 0.01422882080078125
▁any 0.00019681453704833984
▁questions 0.005474090576171875
▁you 0.0023040771484375
▁may 0.0033092498779296875
▁have 0.00032830238342285156
▁regarding 0.004329681396484375
▁a 0.021240234375
▁medical 0.003215789794921875
▁condition 0.0079345703125
. 0.1412353515625
